Do Florida Medicaid providers' barriers to HPV vaccination vary based on VFC program participation?

Maternal and Child Health Journal
Teri L MaloSusan T Vadaparampil

Abstract

This study aimed to determine if physicians' perceived barriers to human papillomavirus (HPV) vaccination were associated with participation in the federal Vaccines for Children (VFC) program. A sample of 800 Florida Medicaid providers was randomly selected from the Florida Medicaid Master Provider File. A cross-sectional study was conducted using a 27-item survey that included 13 potential barriers to immunizing Medicaid patients against HPV, including concerns about vaccine safety and efficacy, discussing sexuality, vaccinated teens practicing riskier sexual behaviors, cost and reimbursement, ensuring 3-dose series completion, and school attendance requirements associated with HPV vaccination. Pearson χ(2) tests were conducted to investigate differences between each barrier and VFC program participation. Data were analyzed for 449 physicians. Compared to non-VFC providers, VFC providers were significantly less likely to somewhat or strongly agree that the following were barriers to vaccination: the cost of stocking the HPV vaccine (p = 0.0011), lack of adequate reimbursement for HPV vaccination (p < 0.0001), and lack of timely reimbursement for HPV vaccination (p < 0.0001). After adjusting for provider specialty and number of...Continue Reading

References

Aug 1, 1994·Archives of Family Medicine·J M Lyznicki, R C Rinaldi
Dec 4, 2003·The Journal of the American Board of Family Practice·Matthew M DavisSarah J Clark
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alan R HinmanLance Rodewald
Jun 25, 2004·Sexually Transmitted Diseases·Erika SamoffIsaac B Weisfuse
Nov 1, 2005·The American Journal of Geriatric Pharmacotherapy·Richard K ZimmermanDavid G Hall
Mar 15, 2006·Public Health Reports·Sangeeth K GnanasekaranTracy Lieu
Jun 1, 2006·American Journal of Public Health·Shannon StokleyAbigail Shefer
Sep 18, 2007·Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association·Jessica A KahnGregory D Zimet
Mar 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ann AlbrightDesmond E Williams
Aug 4, 2009·Journal of Pediatric and Adolescent Gynecology·Meaghan A LeddyJay Schulkin
Aug 8, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jessica A KahnSusan L Rosenthal
Dec 8, 2009·Journal of Pediatric Psychology·Heather L GambleMary E Randolph
Mar 26, 2010·Journal of Community Health·Emily L McCave
Sep 25, 2010·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Stephanie A S StarasElizabeth A Shenkman
Nov 10, 2010·Annals of Family Medicine·Doug Campos-OutcaltHerbert F Young
Dec 15, 2010·Computer Methods and Programs in Biomedicine·Alan C Elliott, Linda S Hynan
Jun 28, 2011·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Linda J Koenig, Donna Hubbard McCree

❮ Previous
Next ❯

Citations

Aug 22, 2015·Expert Review of Vaccines·Abbey B Berenson
Feb 20, 2019·Human Vaccines & Immunotherapeutics·Paige W LakeSusan T Vadaparampil
Jan 16, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kevin A HenryDeanna Kepka
Dec 18, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jennifer L MossNoel T Brewer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.